menu
    • menu

    Company profile for Insilico Medicine

    NEW Drugs in Dev: 15
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our Mission is to extend healthy longevity through innovative AI solutions for drug discovery and aging research. We aspire to be a leader in the field of deep learning for drug discovery, personalized healthcare, and anti-aging interventions. We developed a comprehensive drug discovery engine, which utilizes millions of samples and multiple data types to discover signatures of disease and identify the most promising targets f...
    Our Mission is to extend healthy longevity through innovative AI solutions for drug discovery and aging research. We aspire to be a leader in the field of deep learning for drug discovery, personalized healthcare, and anti-aging interventions. We developed a comprehensive drug discovery engine, which utilizes millions of samples and multiple data types to discover signatures of disease and identify the most promising targets for billions of molecules that already exist or can be generated de novo with the desired set of parameters.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Insilico MedicineHongKong Flag
    Country
    Country
    Hong Kong
    Address
    Address
    Rm 8, Unit 111-113 ICT Co-Working Centre 1/F Enterprise Place, 5 Science Park ...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://insilico.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/in-silico-medicine
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/insilicomeds?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Insilico Medicine Names Halle Zhang Vp, Clinical Development -
    Insilico Medicine Names Halle Zhang Vp, Clinical Development -

    06 Feb 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/insilico-medicine-appoints-halle-zhang-phd-med-as-vice-president-clinical-development--oncology-302681141.html

    PR NEWSWIRE BIO
    06 Feb 2026
    Share Share
    Insilico Medicine Nominates Ai-Powered GIPR Antagonist ISM0676
    Insilico Medicine Nominates Ai-Powered GIPR Antagonist ISM0676

    29 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/up-to-31-3-body-weight-loss-insilico-medicine-nominates-ai-powered-gipr-antagonist-ism0676-as-preclinical-candidate-showing-synergistic-efficacy-in-combination-therapy-302673640.html

    PR NEWSWIRE
    29 Jan 2026
    Share Share
    Qilu Inks $120M, AI-Enabled Cardiometabolic Pact With Insilico
    Qilu Inks $120M, AI-Enabled Cardiometabolic Pact With Insilico

    27 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/qilu-programs-path-cardiometabolic-disease-120m-ai-enabled-insilico-alliance

    FIERCE BIOTECH
    27 Jan 2026
    Share Share
    Insilico Medicine Gets FDA Nod For Ai-Backed NLRP3 Inhibitor
    Insilico Medicine Gets FDA Nod For Ai-Backed NLRP3 Inhibitor

    23 Jan 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/insilico-medicine-receives-ind-approval-from-fda-for-ism8969-an-ai-empowered-potential-best-in-class-nlrp3-inhibitor-302668158.html

    PR NEWSWIRE BIO
    23 Jan 2026
    Share Share
    Insilico Medicine Launches MMAI Gym To Elevate LLMs Into Pharma
    Insilico Medicine Launches MMAI Gym To Elevate LLMs Into Pharma

    22 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/insilico-medicine-launches-science-mmai-gym-to-transform-frontier-llms-into-pharmaceutical-grade-scientific-engines-302668169.html

    PR NEWSWIRE
    22 Jan 2026
    Share Share
    Insilico Agrees To $66M Deal To Split Rights For NLRP3 Inhibitor
    Insilico Agrees To $66M Deal To Split Rights For NLRP3 Inhibitor

    21 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/insilico-agrees-66m-deal-split-rights-preclinical-nlrp3-inhibitor-new-chinese-biotech

    FIERCE BIOTECH
    21 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search